Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02973113
Title Nivolumab With Epstein Barr Virus Specific T Cells (EB-VSTS), Relapsed/Refractory EBV Positive Lymphoma (PREVALE) (PREVALE)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Baylor College of Medicine
Indications

non-Hodgkin lymphoma

Hodgkin's lymphoma

B-cell lymphoma

mature T-cell and NK-cell lymphoma

Therapies

EB-VST cells + Nivolumab

Age Groups: child | adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Houston Methodist Hospital Houston Texas 77030 United States Details
Texas Children's Hospital Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field